In Vitro Model Services
-
Manufactured by Cytes Biotechnologiesbased in SPAIN
Cytes Biotechnologies, S.L offers several services to the research community, based on cells isolation and in vitro research ...
-
Manufactured by Mimetas B.V.based in NETHERLANDS
Capture and understand human disease biology in vitro. The key to unlocking effective therapies for the unsolved diseases of our times is a deep understanding of human disease biology. To this end, MIMETAS aims to capture the essence of diseases in fit-for-purpose in vitro models. We are fully committed to reducing human disease ...
-
Manufactured by Curi Biobased in USA
Curi Bio has a repository of iPSC’s for disease modeling and proprietary technologies for differentiating these cells into myoblasts and cardiomyocytes. Curi has developed in vitro 3D disease models for multiple disease phenotypes. In addition, Curi has the capability of generating new gene-edited iPSC models in ...
-
Manufactured by Alcyomics Ltd.based in UNITED KINGDOM
Development of complex and functional high-throughput in-vitro 3D tissue models for replicating disease states and high-throughput molecule ...
-
Manufactured by Newcells Biotech Limitedbased in UNITED KINGDOM
are not always predictive of human responses. To address this problem, robust, comparative in vitro kidney transporter models, such as aProximate™, are powerful tools to compare different species and are much needed to improve in vitro-in vivo extrapolation ...
-
Manufactured by Newcells Biotech Limitedbased in UNITED KINGDOM
In vitro retinal disease modelling for retinal therapy. Newcells offers a fast and reliable in vitro safety and efficacy service for the evaluation of novel compounds for retinal therapy using complex human retinal organoid or RPE models developed in house. Both models are iPSC derived allowing gene-edited lines ...
-
Manufactured by Neuron Biobased in SPAIN
projects through the use of in vitro and in vivo models (efficacy and safety, behavior studies …) in multiple areas of ...
-
Manufactured by InnoSer Belgie NVbased in BELGIUM
In vitro and in vivo methods to provide a study setup that thoroughly determines safety and efficacy. ...
-
Manufactured by CENTOGENE N.V.based in GERMANY
We work with partners to develop new disease models and new biomarkers of disease. We can also use our disease models to identify new drug targets and screen chemical compounds to identify potential new drug candidates. CENTOGENE provides companies with tools to accelerate drug discovery. From population screening studies that ...
-
by Oncodesignbased in FRANCE
Establishing proof of concept in preclinical pharmacology is a critical step in the drug discovery process. This is one of the decisive factors in setting the therapeutic indication(s) targeted in clinical models and in the decision to continue a new product through the regulatory preclinical and clinical steps. For more than 25 years, ...
-
Manufactured by InnoSer Belgie NVbased in BELGIUM
We move your identified hits forward into in vivo testing and lead optimization. As a critical phase in your drug development journey, the hit to lead phase will determine which of your promising compounds will be characterized against your targets. With a lean ethos, InnoSer is dedicated to combining our expertise with your drug development goals in the most resource efficient way. During this ...
-
Manufactured by InnoSer Belgie NVbased in BELGIUM
We optimize your lead compounds using expertise and data-driven decisions. The lead optimization stage marks the end of the drug discovery phase and the start of pharmaceutical or biological development. Insight into the absorption, distribution, metabolism, and excretion (ADME) is key to progressing your identified lead compounds after the hit to lead phase. ...
-
by iFyber, LLCbased in USA
and remove. Research has shown that between 60 to 90% of chronic wounds are associated with biofilms. The development of technologies to combat resistant biofilm infections often requires custom biofilm test models. Biofilm tests at iFyber can be tailored to evaluate technologies in a way that meets the client’s ...
-
Manufactured by InnoSer Belgie NVbased in BELGIUM
We offer multi-validation solutions for preclinical targets across numerous therapeutic fields. ...
-
Manufactured by SynVivo, Inc.based in USA
The SynVivo platform has been validated for accurate prediction of in vivo responses. Use this unique in vitro platform for realistic assessment of drug delivery, analysis of cell-cell, cell-drug, and their underlying mechanisms. Recreate cellular and tissue architecture in a Organ-on-Chip format compatible with standard analytical ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you